Trial Radar AI

Let's discuss and explore clinical trials with MD Anderson Cancer Center as a lead sponsor or collaborator.

Showing clinical trials matching location: The University of Texas M. D. Anderson Cancer Center.

I can help you find nearby clinical trials and understand health conditions and treatments.
22 Clinical Trials
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Location
The University of Texas M. D. Anderson Cancer Center
×
 
Study Title
Status
PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System NCT07444645
Not yet recruiting
Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies NCT07444632
Not yet recruiting
A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas NCT07444619
Not yet recruiting
Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases NCT07444606
Not yet recruiting
Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer NCT07415005
Not yet recruiting
Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma NCT07414979
Not yet recruiting
Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia NCT07411586
Not yet recruiting
Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms NCT07382817
Recruiting
Decoupling Immunotherapy Toxicity and Cancer Response NCT07382752
Recruiting
Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial NCT07382726
Not yet recruiting
Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System NCT07382557
Recruiting
Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss NCT07382544
Recruiting
Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer NCT07377526
Not yet recruiting
A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses NCT07369050
Not yet recruiting
CARE-BI:a Pilot Study to Improve Patient Comfort and Reduce Psychological Distress During IA Removal NCT07335302
Recruiting
IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) Intervention NCT07318363
Not yet recruiting
Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma NCT07316010
Not yet recruiting
Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia NCT07311746
Not yet recruiting
A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE) NCT07298096
Recruiting
DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins NCT07298083
Not yet recruiting
Phase I/II Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma NCT07283679
Not yet recruiting
Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase NCT07269470
Not yet recruiting